Interferon regulatory factor 7 (IRF7) represents a link between inflammation and fibrosis in the pathogenesis of systemic sclerosis.
Minghua WuBrian SkaugXiongjie BiTingting MillsGloria SalazarXiaodong ZhouJohn ReveilleSandeep K AgarwalMichael R BlackburnMaureen D MayesShervin AssassiPublished in: Annals of the rheumatic diseases (2019)
IRF7 is upregulated in SSc skin, interacts with Smad3 and potentiates TGF-β-mediated fibrosis, and therefore may represent a promising therapeutic target in SSc.